In particular, Oct4 is an embryonic stem cell marker, whose expression has been reported as being an independent prognostic factor in hormone-receptor-positive breast cancer associated with ALDH1 positivity, high proliferative ki67 index, and high histological tumour grade [46]. Here, ALDH1A1 is linked to neoplasm.